DE2659217A1 - Prostaglandin-analoga - Google Patents

Prostaglandin-analoga

Info

Publication number
DE2659217A1
DE2659217A1 DE19762659217 DE2659217A DE2659217A1 DE 2659217 A1 DE2659217 A1 DE 2659217A1 DE 19762659217 DE19762659217 DE 19762659217 DE 2659217 A DE2659217 A DE 2659217A DE 2659217 A1 DE2659217 A1 DE 2659217A1
Authority
DE
Germany
Prior art keywords
formula
compound
acid
methyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762659217
Other languages
German (de)
English (en)
Inventor
Norman Allan Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE2659217A1 publication Critical patent/DE2659217A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762659217 1976-01-08 1976-12-28 Prostaglandin-analoga Withdrawn DE2659217A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/647,363 US4028419A (en) 1976-01-08 1976-01-08 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds

Publications (1)

Publication Number Publication Date
DE2659217A1 true DE2659217A1 (de) 1977-07-21

Family

ID=24596693

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762659217 Withdrawn DE2659217A1 (de) 1976-01-08 1976-12-28 Prostaglandin-analoga

Country Status (9)

Country Link
US (17) US4028419A (enExample)
JP (1) JPS5289648A (enExample)
AU (1) AU502586B2 (enExample)
BE (1) BE850202A (enExample)
CH (1) CH627428A5 (enExample)
DE (1) DE2659217A1 (enExample)
FR (1) FR2337713A1 (enExample)
NL (1) NL7700114A (enExample)
ZA (1) ZA767540B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824844A1 (de) * 1977-08-12 1979-02-15 Otsuka Kagaku Yakuhin 2-(2-pentinyl)-cyclopentanolderivate

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167624A (en) * 1977-07-14 1979-09-11 The Upjohn Company 5-Hydroxy-PGI1 pyrrolinylamides
US4166903A (en) * 1977-07-14 1979-09-04 The Upjohn Company 5-Hydroxy-PGI1 pyrrolidylamides
US4110532A (en) * 1977-07-14 1978-08-29 The Upjohn Company 5-Hydroxy-PGI1 compounds
US4170703A (en) * 1977-07-14 1979-10-09 The Upjohn Company 5-Hydroxy-PGI1 morpholinylamides
US4158018A (en) * 1978-09-12 1979-06-12 Miles Laboratories, Inc. 3-Oxa carbinol prostaglandin analogs
US4322543A (en) * 1979-11-28 1982-03-30 G. D. Searle & Co. 4,5-Unsaturated prostanoic acid derivatives
US4271314A (en) * 1979-11-28 1981-06-02 G. D. Searle & Co. 4,5-Unsaturated prostanoic acid derivatives
JPS591463A (ja) * 1982-06-28 1984-01-06 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
GB8625322D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334952A (en) * 1971-01-06 1973-10-24 Ici Ltd Cyclopentane derivat-ves and a process for their manufacture
US3962312A (en) * 1972-09-21 1976-06-08 Ono Pharmaceutical Company 9,11,15-Trihydroxy prost-5-enoic acid analogues
US3933892A (en) * 1973-02-12 1976-01-20 Hoffmann-La Roche Inc. Asymmetric synthesis of optically active prostaglandins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824844A1 (de) * 1977-08-12 1979-02-15 Otsuka Kagaku Yakuhin 2-(2-pentinyl)-cyclopentanolderivate

Also Published As

Publication number Publication date
US4067907A (en) 1978-01-10
US4066700A (en) 1978-01-03
US4066701A (en) 1978-01-03
US4076750A (en) 1978-02-28
US4088691A (en) 1978-05-09
JPS5289648A (en) 1977-07-27
US4100198A (en) 1978-07-11
ZA767540B (en) 1977-11-30
US4076753A (en) 1978-02-28
US4093659A (en) 1978-06-06
US4066702A (en) 1978-01-03
FR2337713B1 (enExample) 1983-05-20
US4073805A (en) 1978-02-14
US4088690A (en) 1978-05-09
NL7700114A (nl) 1977-07-12
AU2068276A (en) 1978-06-22
CH627428A5 (de) 1982-01-15
AU502586B2 (en) 1979-08-02
US4076751A (en) 1978-02-28
BE850202A (fr) 1977-07-07
US4097537A (en) 1978-06-27
FR2337713A1 (fr) 1977-08-05
US4075247A (en) 1978-02-21
US4028419A (en) 1977-06-07
US4076752A (en) 1978-02-28
US4088692A (en) 1978-05-09

Similar Documents

Publication Publication Date Title
DE2659215A1 (de) Prostaglandin-analoga
DE2704933A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
DE2423155A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
US4033989A (en) 9-Deoxy-PGF2 Analogs
DE2641823A1 (de) Neue prostaglandin-analoga
DE2627674A1 (de) Prostaglandinartige 1,11-lactone und ein verfahren zu ihrer herstellung
DE2659217A1 (de) Prostaglandin-analoga
DE2659216A1 (de) Prostaglandin-analoga
DE2658207A1 (de) Prostaglandinanaloga und verfahren zu deren herstellung
DE2638827A1 (de) Neue 11-deoxy-prostaglandine e, f tief alpha und f tief beta
DE2423156A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
DE2627672A1 (de) Prostaglandinartige 1,15-lactone und verfahren zu deren herstellung
DE2610718A1 (de) Neue 16-phenoxy-prostaglandin-verbindungen
DE2719901A1 (de) Pge- und 11-deoxy-pge-verbindungen mit einer methylengruppe am c-9
DE2704932A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
DE2830478C2 (de) Prostaglandin-Analoge
DE2606051A1 (de) 2,2-difluor-prostaglandin-e, -f tief alpha, -f tief beta, -a und -b-analoga und verfahren zu deren herstellung
DE2724555A1 (de) 5,6-dihydro-prostacyclin-analoge und verfahren zu deren herstellung
CH623570A5 (enExample)
DE2542686A1 (de) 2a,2b-dihomo-15-methyl- und -15- aethyl-pgf-und pge-verbindungen und verfahren zu deren herstellung
DE2704958A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
DE2704959A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE2704960A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
CH629737A5 (de) Verfahren zur herstellung von neuen prostaglandin-analogen mit primaerer hydroxylgruppe am c-1 und dreifachbindung zwischen c-13 und c-14.

Legal Events

Date Code Title Description
8130 Withdrawal